MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway

Obata, T; Tsutsumi, K; Ueta, E; Oda, T; Kikuchi, T; Ako, S; Fujii, Y; Yamazaki, T; Uchida, D; Matsumoto, K; Horiguchi, S; Kato, H; Okada, H; Otsuka, M

Tsutsumi, K; Otsuka, M (通讯作者)，Okayama Univ Hosp, Dept Gastroenterol & Hepatol, 2-5-1 Shikata Cho,Kita Ku, Okayama, Okayama 7008558, Japan.

MOLECULAR THERAPY NUCLEIC ACIDS, 2023; 34 ():

Abstract

Gemcitabine is an effective chemotherapeutic agent for biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA). ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索